调节性T细胞在肺衰老和COPD发展中的作用
Virginija Šileikienė1, Laimutė Jurgauskienė2
1Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
International journal of molecular sciences
|May 7, 2025
概括
调节T细胞 (Tregs) 在慢性阻塞性肺病 (COPD) 中调节肺炎方面至关重要. 随着年龄的增长,Treg活性的变化可能解释了老年人常见的免疫状况,包括COPD和加速的肺衰老.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 老年学是一门学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性炎症性肺病,主要是由吸烟引起的.
- 个人对COPD的易感性各不相同,这表明潜在的因素会影响疾病的发展.
- 调节性T细胞 (Tregs) 在免疫调节中发挥关键作用,并与COPD的发病有关.
研究的目的:
- 审查关于Treg细胞在COPD病变发生过程中的作用的文献.
- 探索Treg细胞对肺衰老的影响.
- 了解将衰老,Tregs和COPD联系在一起的免疫机制.
主要方法:
- 对Treg细胞和COPD现有研究的文献综述.
- 分析与衰老相关的免疫变化.
- 检查Treg介导免疫抑制在各种疾病中的作用.
主要成果:
- 在COPD中调节肺炎时,Treg细胞的活动至关重要.
- 慢性肺炎与加速的肺衰老有相似之处.
- 与Treg细胞的年龄相关的变化与免疫反应的降低和对免疫疾病的敏感性增加有关.
结论:
- 在COPD中观察到的免疫失调中,Treg细胞是核心的.
- 随着年龄的增长而改变的Treg功能可能会导致COPD的发展和进展.
- 了解Treg动态,可以了解与衰老相关的肺部疾病和免疫状况.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
179
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
179
COPD: Management Using Bronchodilators and Corticosteroids
125
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
125
T Cell Types and Functions
627
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
627
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K


